You already vaccinate well. This learning path is about the moments that still cost you: the high-risk patient who slips through on a busy Saturday, the co-administration there wasn’t time to raise, and the patient whose hesitancy runs deeper than a quick answer can fix.
Built for pharmacies where vaccination is already part of the workflow, this path refines what works rather than rebuilding it. Start with the 30-minute accredited core on current NACI guidance for influenza, COVID-19 and RSV, then continue through the practical courses matched to where you are in the season.
How to access the courses
Select TAKE THIS COURSE above after logging in to open the full learning path, where the courses appear together and you can follow them in order. Or select Start the Course below to open an individual course directly that can also lead you back to the learning path.
Peak Performance Core: High-Risk Patients, Co-Administration and NACI Updates
Identify high-risk patients and co-administration opportunities across influenza, COVID-19 and RSV, using the latest NACI guidance.
The Head Start: Reach Your Highest-Risk Patients Now
Start now to reach your highest-risk patients, with priority lists, a team that’s ready on day one, and community outreach.
The High-Volume Playbook: Keep Quality Up When the Line Is Out the Door
Use delegation and workflow strategies to keep recommendation quality high, even at peak volume.
When a Quick Answer Isn’t Enough: Navigating Complex Hesitancy
Use the AIMS framework to work through complex hesitancy and recognize when to involve the pharmacist.
Announce • Inquire • Mirror • Secure
Closing Vaccination Gaps: Turning Missed Opportunities into Sustained Action
Recover missed opportunities during the same visit and make catching them a team habit.
Start the Course
Building a Sustainable Vaccine Workflow: A Year-Round Strategy
Keep your vaccine routine running beyond respiratory season, so next season starts strong.
Start the Course
This program has received financial support from Moderna Canada Inc. in the form of an unrestricted educational grant.